Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
13.35
-0.09 (-0.67%)
At close: Jun 26, 2026, 4:00 PM EDT
13.35
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Design Therapeutics Employees
Design Therapeutics had 54 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
54
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,290,981
Market Cap
833.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 371 |
| Geron | 258 |
| ARS Pharmaceuticals | 159 |
| Aura Biosciences | 113 |
| Odyssey Therapeutics | 100 |
| Annexon | 93 |
| Inventiva | 77 |
| Vor Biopharma | 76 |
DSGN News
- 23 days ago - Design Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Design Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Design Therapeutics Transcript: Status update - Transcripts
- 5 weeks ago - Design Therapeutics Press release: Status update - Filings
- 5 weeks ago - Design Therapeutics Slides: Status update - Filings
- 5 weeks ago - Design Therapeutics announces biomarker, clinical data from RESTORE-FA trial - TheFly
- 5 weeks ago - Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia - GlobeNewsWire
- 5 weeks ago - Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich's Ataxia on Monday, May 18, 2026 - GlobeNewsWire